ID: ALA3289012

Max Phase: Preclinical

Molecular Formula: C24H31NO5

Molecular Weight: 413.51

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2ccc3c(ccn3C)c2)C(=O)O1

Standard InChI:  InChI=1S/C24H31NO5/c1-4-6-18(7-5-2)22(27)29-16-24(15-26)14-20(23(28)30-24)13-17-8-9-21-19(12-17)10-11-25(21)3/h8-13,18,26H,4-7,14-16H2,1-3H3/b20-13+

Standard InChI Key:  YHESSERBDSKRDZ-DEDYPNTBSA-N

Associated Targets(Human)

Protein kinase C alpha 5923 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein kinase C epsilon 1520 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

RAS guanyl releasing protein 3 130 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

RAS guanyl-releasing protein 1 22 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein kinase C delta 2953 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein kinase C (PKC) 1010 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 413.51Molecular Weight (Monoisotopic): 413.2202AlogP: 4.00#Rotatable Bonds: 9
Polar Surface Area: 77.76Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.83CX LogD: 4.83
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.50Np Likeness Score: 0.48

References

1. Garcia LC, Donadío LG, Mann E, Kolusheva S, Kedei N, Lewin NE, Hill CS, Kelsey JS, Yang J, Esch TE, Santos M, Peach ML, Kelley JA, Blumberg PM, Jelinek R, Marquez VE, Comin MJ..  (2014)  Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRP.,  22  (12): [PMID:24794745] [10.1016/j.bmc.2014.04.024]

Source